(Press-News.org) FLORIDA, March 19, 2013 – The Journal of Neuroscience has published a study led by researchers at the Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, that may hold a stunning breakthrough in the fight to treat Alzheimer's disease. The study potentially identifies a cause of Alzheimer's disease—based on a newly-discovered signaling pathway in cellular models of Alzheimer's disease—and opens the door for new treatments by successfully blocking this pathway. The Institute, which recently opened in December 2012, focuses solely on basic neuroscience research that aims to analyze, map, and decode the human brain—the most important and least understood organ in the body.
"This study transforms our understanding of the direct cause of Alzheimer's disease," said Principal Investigator Dr. Ryohei Yasuda. "With further research, we may open up an entirely new avenue for treatments to combat this disease."
The scientific community so far has widely accepted that Alzheimer's disease is caused by the accumulation of a peptide called Amyloid beta. When Amyloid beta is applied to neurons, neuronal morphology becomes abnormal and synaptic function is impaired. However, how Amyloid beta causes dysfunction is unknown. The MPFI research indicates that the presence of Amyloid beta triggers increased levels of a signaling protein, called centaurin-1 (CentA1), that appears to cause neuronal dysfunction – a potentially groundbreaking discovery that uncovers an important intermediary step in the progression of the disease.
As part of the research, the scientists were able to identify CentA1 and measure its negative effects on neurons. Utilizing an RNA silencing technique, they turned down the cellular production of CentA1, and showed that affected neurons, exposed to Amyloid beta and exhibiting Alzheimer's related symptoms, returned to normal morphology and synaptic function, even with the continued presence of Amyloid beta. They further found that increased CentA1 activates a series of proteins, and these proteins form a signaling pathway from CentA1 to neuronal dysfunction. Thus, inhibiting other proteins in the pathway also "cured" affected neurons.
The initial tests reported were conducted on rat brain slices. MPFI has already started to expand their studies to mouse models of Alzheimer's disease and preliminary experiments show promising results. Ultimately, targeting the components of this newly identified signaling pathway has the potential to open the door for new pharmacological and gene therapies in treatment of Alzheimer's disease. Dr. Yasuda also anecdotally reports that the effects of CentA1 knock down were observed to be sustained over several weeks and an avenue for future study will be to examine how long the positive effects on neurons are sustained which may indicate the potential impact of treatments derived from this research. The full study will be available at http://www.jneurosci.org/ on March 20, 2013.
INFORMATION:
About the Max Planck Florida Institute for Neuroscience
The Max Planck Florida Institute for Neuroscience is the first American institute established by Germany's prestigious Max Planck Society. It brings together top research neuroscientists from around the world to collaborate on unlocking the mysteries of the brain—the most important and least understood organ in the body—by providing new insight into the functional organization of the nervous system, and its capacity to produce perception, thought, language, memory, emotion, and action. The Max Planck Florida Institute for Neuroscience meets this challenge by forging links between different levels of analysis—genetic, molecular, cellular, circuit, and behavioral—and developing new technologies that make cutting edge scientific discoveries possible. The results of the research will be shared publicly with scholars, universities and other institutions around the globe to advance life-saving and life-improving treatments and cures for brain disorders ranging from autism, to Parkinson's to Alzheimer's. For more information, visit http://www.maxplanckflorida.org.
Max Planck Florida Institute study points to major discovery for Alzheimer's disease
2013-03-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
First of its kind study in Canada looks at who is taking aspirin to prevent heart attack or stroke
2013-03-20
A new study out of the Faculty of Medicine & Dentistry shows a large population of healthy people are taking Aspirin to prevent cardiovascular disease, despite the fact that new literature shows it isn't as beneficial as once thought.
Olga Szafran and Mike Kolber, in the Department of Family Medicine at the University of Alberta, surveyed patients over the age of 50 at two clinics in Alberta. They found that more than 40 per cent of people who don't suffer from cardiovascular disease are popping pills daily to prevent a heart attack or stroke – a practice called primary ...
More career options may explain why fewer women pursue jobs in science and math
2013-03-20
Women may be less likely to pursue careers in science and math because they have more career choices, not because they have less ability, according to a new study published in Psychological Science, a journal of the Association for Psychological Science.
Although the gender gap in mathematics has narrowed in recent decades, with more females enrolling and performing well in math classes, females are still less likely to pursue careers in science, technology, engineering, and mathematics (STEM) than their male peers.
Researchers tend to agree that differences in math ...
Fantastic flash memory combines graphene and molybdenite
2013-03-20
After the molybdenite chip, we now have molybdenite flash memory, a significant step forward in the use of this new material in electronics applications. The news is even more impressive because scientists from EPFL's Laboratory of Nanometer Electronics and Structures (LANES) came up with a truly original idea: they combined the advantages of this semiconducting material with those of another amazing material – graphene. The results of their research have recently been published in the journal ACS Nano.
Two years ago, the LANES team revealed the promising electronic ...
Are survivors of childhood leukemia and lymphoma at greater risk of chronic fatigue as adults?
2013-03-20
New Rochelle, NY, Mar 19, 2013—Chronic fatigue, a persistent lack of energy that does not improve with rest, is at least three times more prevalent among adult survivors of acute lymphoblastic leukemia and lymphoma experienced during childhood or adolescence than in the general adult population, according to an article in Journal of Adolescent and Young Adult Oncology (JAYAO), (http://www.liebertpub.com/JAYAO) a multidisciplinary peer-reviewed publication from Mary Ann Liebert, Inc., publishers. (http://www.liebertpub.com) JAYAO is the Official Journal of the Society for ...
Biennial mammograms best after 50, even for women with dense breasts
2013-03-20
Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer "false positives" – even for women whose breasts are dense or who use hormone therapy for menopause.
That is the finding of a new national study involving more than 900,000 women.
The study was published on March 18 in JAMA Internal Medicine.
The same team of researchers from UC San Francisco and Seattle-based Group Health Research Institute recently reported similar results for older women ages 66 to 89 years old.
By contrast, ...
Record simulations conducted on Lawrence Livermore supercomputer
2013-03-20
LIVERMORE, Calif. -- Researchers at Lawrence Livermore National Laboratory have performed record simulations using all 1,572,864 cores of Sequoia, the largest supercomputer in the world. Sequoia, based on IBM BlueGene/Q architecture, is the first machine to exceed one million computational cores. It also is No. 2 on the list of the world's fastest supercomputers, operating at 16.3 petaflops (16.3 quadrillion floating point operations per second).
The simulations are the largest particle-in-cell (PIC) code simulations by number of cores ever performed. PIC simulations ...
To make health systems more effective, physicians say time is now for clinician-led innovation
2013-03-20
(Boston) –Physician experts in health system issues propose a timely alternative process for harnessing and supporting physician-led innovations to rapidly address front-line health care delivery problems and improve health. Published as a Viewpoint article in the March 20th issue of the Journal of the American Medical Association (JAMA), the authors propose health systems adopt a strategy widely accepted in U.S. industries of "user-led" innovation.
User-led innovation is predicated on the idea that important enhancements to products and services are often made by users ...
University of Maryland researchers identify fish protein that may inhibit cancer metastasis
2013-03-20
BALTIMORE – March 19, 2013. Researchers at the University of Maryland School of Medicine have identified a peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences (PNAS).
"The use of natural dietary products with anti-tumor activity is an important and emerging field of research," says senior author Hafiz Ahmed, Ph.D., assistant professor of biochemistry and molecular biology at the University of Maryland ...
Transportation study reveals potential for deep cuts to petroleum use and carbon emissions
2013-03-20
The U.S. Department of Energy's (DOE) National Renewable Energy Laboratory (NREL) and Argonne National Laboratory (ANL) today announced the release of the Transportation Energy Futures (TEF) study, an assessment of avenues to reach deep cuts in petroleum use and greenhouse gas (GHG) emissions in the transportation sector.
"Transportation is an engine of our economic strength, but it also represents a key challenge for the future of U.S. energy use," NREL Senior Analyst Austin Brown said. "Transportation accounts for 71 percent of total U.S. petroleum consumption and 33 ...
Highlights from the March GIE: Gastrointestinal Endoscopy special issue on colorectal cancer
2013-03-20
OAK BROOK, Ill. – March 19, 2013 – In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer. The issue includes a practical guide for approaching and managing serrated colon polyps, one of the most common types of polyps, and a study on reducing postpolypectomy bleeding with prophylactic clip closure. GIE: Gastrointestinal Endoscopy is the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
"The cutting edge of serrated ...